Who owns CHINA SXT PHARMACEUTICALS IN?
- Ticker: SXTC
- CUSIP Number: g2161p157
Tip: Access positions for across all investors
Analyze quarterly positions in China Sxt Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of China Sxt Pharmaceuticals In stock
Who bought or sold CHINA SXT PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| XTX Topco | 23k | $36k | 100% | Dec 2025 |
|
| Virtu Financial | 12k | $20k | -57% | Dec 2025 |
|
| Tower Research Capital | 1.8k | $2.9k | -37% | Dec 2025 |
|
Who sold out of China Sxt Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 151k | $241k |
| Invesco | Dec 2025 | 85k | $137k |
| Geode Capital Management | Dec 2025 | 54k | $86k |
| Renaissance Technologies | Sep 2025 | 45k | $70k |